Zobrazeno 1 - 10
of 16
pro vyhledávání: '"33"'
Autor:
Etienne, De Braekeleer, Nathalie, Douet-Guilbert, Frédéric, Morel, Marie-Josée, Le Bris, Audrey, Basinko, Christian, Berthou, Patrick, Morice, Claude, Férec, Marc, De Braekeleer
Publikováno v:
Anticancer research. 30(2)
The Philadelphia (Ph) chromosome, resulting from a t(9;22)(q34;q11), is one of the most frequent chromosomal abnormalities observed among patients with acute lymphoblastic leukemia (ALL). Main of study: To analyze the distribution of Ph chromosome-po
Autor:
Hideo Baba, Taishi Yamane, Shinya Shimada, Kei Horino, Daisuke Izumi, Chika Shirakami, Keisuke Morita, Satoshi Ikeshima, Shotaro Kinoshita
Publikováno v:
Anticancer Research. 41:5223-5229
AIM The aim of the current study was to investigate whether the artery-first approach (AFA) improved surgical outcomes of pancreaticoduodenectomy (PD) at our non-high-volume center. PATIENTS AND METHODS We retrospectively reviewed data on 121 consecu
Autor:
Takahiko Nakamura, Kenjiro Tsuruoka, Kiyoe Kanaoka, Yosuke Tamura, Yasuhito Fujisaka, Soichiro Ikeda, Tomoya Funamoto, Masafumi Imanishi, Isao Goto, Akihisa Imagawa, Hiroyuki Tsuji, Sho Mitsuya, Ninso Matsunaga
Publikováno v:
Anticancer Research. 41:5137-5145
BACKGROUND For epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC), administration of EGFR tyrosine kinase inhibitors (TKIs) is mandatory to prolong survival. To date, a comparison of second- and third-generation EGFR-T
Autor:
YUKARI BANDO, JUNYA FURUKAWA, YASUYOSHI OKAMURA, TAKUTO HARA, TOMOAKI TERAKAWA, YUZO NAKANO, MASATO FUJISAWA
Publikováno v:
Anticancer research. 42(2)
The survival benefit of immune checkpoint inhibitors for non-clear cell renal cell carcinoma (nccRCC) is unclear. Our purpose was to evaluate the real-world survival benefit of ipilimumab plus nivolumab retrospectively.We retrospectively reviewed med
Autor:
Takayuki Shiraki, Takatsugu Matsumoto, Takamune Yamaguchi, Yukihiro Iso, Yuhki Sakuraoka, Taku Aoki, Keiichi Kubota, Shozo Mori, Takayuki Shimizu, Kyung Hwa Park
Publikováno v:
Anticancer research. 41(10)
BACKGROUND/AIM The efficacy and feasibility of gemcitabine plus cisplatin (GC) chemotherapy in an adjuvant setting is unclear in patients with biliary tract cancer (BTC) undergoing major hepatectomy. PATIENTS AND METHODS Patients with BTC who underwe
Autor:
Takaaki, Fujii, Toshinaga, Sutoh, Hiroki, Morita, Reina, Yajima, Satoru, Yamaguchi, Soichi, Tsutsumi, Takayuki, Asao, Hiroyuki, Kuwano
Publikováno v:
Anticancer research. 34(6)
We previously showed that the presence of vascular invasion, but not lymphatic invasion, was a strong prognostic factor for breast cancer. Lymphatic invasion may represent mainly the selective affinity of cancer cells for lymph nodes. The present stu
Autor:
Hideki, Kawai, Akira, Ishii, Kiyotada, Washiya, Toshiko, Konno, Hiroto, Kon, Chiharu, Yamaya, Iwao, Ono, Junichi, Ogawa
Publikováno v:
Anticancer research. 25(6C)
The aim of the present study was to determine the prognostic significance of the combined overexpression of epidermal growth factor receptor (EGFR) and estrogen receptor a (ER-alpha) in non-small cell lung cancer (NSCLC).An immunohistochemical assess
Autor:
Takashi, Yoshimatsu, Hidetaka, Uramoto, Tsunehiro, Oyama, Yasunori, Yashima, Chundong, Gu, Masaru, Morita, Kenji, Sugio, Kimitoshi, Kohno, Kosei, Yasumoto
Publikováno v:
Anticancer research. 25(5)
Transcription factor Y-box-binding protein 1 (YB-1), which binds to the inverted CCAAT box, is not only involved in the transcription of various genes, but also in cell proliferation and DNA repair. The aim of this study was to detect YB-1 and p53 ex
Autor:
Feng, Xu, Wang, Zhong, Jichang, Li, Zhang, Shanshen, Jianguo, Cui, Jahn M, Nesland, Zhenhe, Suo
Publikováno v:
Anticancer research. 25(4)
The aim of this study was to analyse the protein and mRNA expressions of EphA2 and EphrinA-1 in oesophageal squamous cell carcinomas and to explore their clinicopathological associations and predictive values in oesophageal squamous cell carcinoma. T
Publikováno v:
Anticancer research. 21(6A)
The role of hepatectomy for metastases from non-colorectal (NCR) and non-neuroendocrine (NNE) tumors has not been defined. We analyzed several factors of the primary tumor and liver metastases to clarify the prognostic determinants.From 1990 to 1995,